ETB receptor antagonist, IRL 1038, selectively inhibits the endothelin-induced endothelium-dependent vascular relaxation
- 1 February 1993
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 231 (3) , 371-374
- https://doi.org/10.1016/0014-2999(93)90112-u
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 10 references indexed in Scilit:
- An endothelin B receptor‐selective antagonist: IRL 1038, [Cys11‐Cys15]‐endothelin‐1(11–21)FEBS Letters, 1992
- Venous smooth muscle contains vasoconstrictor ETB-like receptorsBiochemical and Biophysical Research Communications, 1992
- Autocrine receptors for endothelins in the primary culture of endothelial cells of human umbilical veinFEBS Letters, 1992
- Molecular characterization of endothelin receptorsTrends in Pharmacological Sciences, 1992
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990
- The activity of peptides of the endothelin family in various mammalian smooth muscle preparationsEuropean Journal of Pharmacology, 1989
- Effects of endothelin on the mechanical activity and cytosolic calcium levels of various types of smooth muscleBritish Journal of Pharmacology, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Low temperature augments the endothelium-dependent relaxation in isolated rat aortaEuropean Journal of Pharmacology, 1987